98 related articles for article (PubMed ID: 9163999)
1. [Arterial hypertension: current large therapeutic trials].
Chalon S; Brudi P; Lechat P
Therapie; 1996; 51(6):631-8. PubMed ID: 9163999
[TBL] [Abstract][Full Text] [Related]
2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
4. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
[TBL] [Abstract][Full Text] [Related]
5. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
[TBL] [Abstract][Full Text] [Related]
6. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
[TBL] [Abstract][Full Text] [Related]
7. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
8. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
10. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
11. [Effect of antihypertensive therapy on the prevalence of ischemic cardiopathy in arterial hypertension. New contributions].
Tamargo J
Rev Esp Cardiol; 1990; 43 Suppl 1():9-17. PubMed ID: 2186456
[TBL] [Abstract][Full Text] [Related]
12. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
13. [Cardiac protection and antihypertensive therapy: facts and theories].
Verdecchia P
Minerva Med; 1986 Jun; 77(26):1259-70. PubMed ID: 3523304
[TBL] [Abstract][Full Text] [Related]
14. Results of the STOP-Hypertension-2 trial.
Hansson L
Blood Press Suppl; 2000; 2():17-20. PubMed ID: 11055467
[TBL] [Abstract][Full Text] [Related]
15. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
16. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive therapy in the elderly: results of large trials].
Leonetti G; Cuspidi C; Facchini M
Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
[TBL] [Abstract][Full Text] [Related]
18. [Drugs and arterial stiffness in hypertensive patients].
Laurent S
Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878
[TBL] [Abstract][Full Text] [Related]
19. Diuretics for cardiovascular prevention in the elderly.
Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee.
Lièvre M; Gueyffier F; Ekbom T; Fagard R; Cutler J; Schron E; Marre M; Boissel JP
Diabetes Care; 2000 Apr; 23 Suppl 2():B65-71. PubMed ID: 10860193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
